Common side effects of Mounjaro include nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion, and/or stomach pain
Owing to glucagons hyperglycaemic and insulin-suppressing effects, the glucagon receptor (GcgR) has historically been a prime target for pharmacological suppression rather than activation
For detailed comparison of these medication options, see our Zepbound vs Wegovy guide
Maiorino M, Gregolin C, Ursini F
7 Why Even Small Weight Loss Matters People who are overweight (BMI in the 25 to 30 range) drop less weight on GLP-1s than those with clinical obesity, losing just 5 to 10 percent of their body weight on average versus 15 to 20 percent for the obese cohort
3.1 System pharmacology of SGLT2 inhibitors The first SGLT2 inhibitors came from phlorizin, a natural plant compound